Mirela Marinela Florescu

Dr. Mirela Marinela Florescu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
AFAlesandra Florescu
Alesandra Florescu
FGFlorin-Liviu Gherghina
Florin-Liviu Gherghina
AMAnca Emanuela Mușetescu
Anca Emanuela Mușetescu
Vlad PadureanuVlad Padureanu
Vlad Padureanu
ARAnca Roșu
Anca Roșu
ABAnca Bobirca
Anca Bobirca
Rheumatoid arthritis (RA) is considered a systemic inflammatory disease marked by polyarthritis which affects the joints symmetrically, leading to progressive damage of the bone structure and eventually joint deformity. Lung involvement is the most prevalent extra-articular feature of RA, affecting 10–60% of patients with this disease. In this review, we aim to discuss the patterns of RA interstitial lung disease (ILD), the molecular mechanisms involved in the pathogenesis of ILD in RA, and also the therapeutic challenges in this particular extra-articular manifestation. The pathophysiology of RA-ILD has been linked to biomarkers such as anti-citrullinated protein antibodies (ACPAs), MUC5B mutation, Krebs von den Lungen 6 (KL-6), and other environmental factors such as smoking. Patients at the highest risk for RA-ILD and those most likely to advance will be identified using biomarkers. The hope is that finding biomarkers with good performance characteristics would help researchers better understand the pathophysiology of RA-ILD and, in turn, lead to the development of tailored therapeutics for this severe RA manifestation.

22 September 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RSRobert Emmanuel Serban
Robert Emmanuel Serban
Mihail Virgil BoldeanuMihail Virgil Boldeanu
Mihail Virgil Boldeanu
DFDan Nicolae Florescu
Dan Nicolae Florescu
MIMihaela Ionescu
Mihaela Ionescu
MȘMircea-Sebastian Șerbănescu
Mircea-Sebastian Șerbănescu
CVCristin Constantin Vere
Cristin Constantin Vere
Background: Colorectal cancer is a major health problem that still causes many deaths worldwide. Neuropeptides, such as substance P and calcitonin gene-related peptide, play the neurotransmitter and neurohormone roles that increase tumor invasiveness and metastasis potential. This study aimed to see whether these neuropeptides and their receptors—neurokinin 1 receptor and calcitonin receptor-like receptor—correlate with the diagnosis stage, tumor differentiation grade, and different patient characteristics in colorectal cancer and also to compare them. Methods: We performed serum analyses of substance P and CGRP levels in patients with colorectal cancer and also the immunohistochemical analysis of their receptors in colorectal tumors and then correlated them with the disease stage and with different tumor characteristics. Results: We demonstrated that both substance P and calcitonin gene-related peptide had increased levels in colorectal cancer and that their levels correlated with the stage of the disease and with the tumor differentiation grade. We also demonstrated the correlation of NK-1R and CRLR higher immunohistochemical scores with advanced and poorly differentiated tumors. Conclusions: This study demonstrates that the neuropeptides SP and CGRP and their receptors NK-1R and CRLR could play a role in the pathogenesis of colorectal cancer, and they could be used as diagnostic and prognostic markers and could represent potential therapeutic targets.

Verified
Journal Article
Open access
PDF file
RSRobert Emmanuel Serban
Robert Emmanuel Serban
MIOARA DESDEMONA STEPANMIOARA DESDEMONA STEPAN
MIOARA DESDEMONA STEPAN
DFDan Nicolae Florescu
Dan Nicolae Florescu
Mihail Virgil BoldeanuMihail Virgil Boldeanu
Mihail Virgil Boldeanu
MFMirela Marinela Florescu
Mirela Marinela Florescu
CVCristin Constantin Vere
Cristin Constantin Vere
Colorectal cancer is one of the most widespread types of cancer that still causes many deaths worldwide. The development of new diagnostic and prognostic markers, as well as new therapeutic methods, is necessary. The calcitonin gene-related peptide (CGRP) neuropeptide alongside its receptor calcitonin receptor-like receptor (CRLR) could represent future biomarkers and a potential therapeutic target. Increased levels of CGRP have been demonstrated in thyroid, prostate, lung, and breast cancers and may also have a role in colorectal cancer. At the tumor level, it acts through different mechanisms, such as the angiogenesis, migration, and proliferation of tumor cells. The aim of this study was to measure the level of CGRP in colorectal cancer patients’ serum by enzyme-linked immunosorbent assay (ELISA) and determine the level of CGRP and CRLR at the tumor level after histopathological (HP) and immunohistochemical (IHC) analysis, and then to correlate them with the TNM stage and with different tumoral characteristics. A total of 54 patients with newly diagnosed colorectal adenocarcinoma were evaluated. We showed that serum levels of CGRP, as well as CGRP and CRLR tumor level expression, correlate with the TNM stage, with local tumor extension, the presence of lymph node metastasis, and distant metastasis, and also with the tumor differentiation degree. CGRP is present in colorectal cancer from the incipient TNM stage, with levels increasing with the stage, and can be used as a diagnostic and prognostic marker and may also represent a potentially new therapeutic target.

23 September 2024 in Life
Verified
Journal Article
Open access
PDF file
Mihaela Andreea PodeanuMihaela Andreea Podeanu
Mihaela Andreea Podeanu
SVStefanita Bianca vintilescu
Stefanita Bianca vintilescu
Claudiu Marinel IoneleClaudiu Marinel Ionele
Claudiu Marinel Ionele
RSRaluca Elena Sandu
Raluca Elena Sandu
CNCarmen Elena Niculescu
Carmen Elena Niculescu
MIOARA DESDEMONA STEPANMIOARA DESDEMONA STEPAN
MIOARA DESDEMONA STEPAN
Obesity is linked to the increasing prevalence of metabolic syndrome (MetS), even among the pediatric population. Some inflammatory and cardioembolic indexes derived from routine laboratory tests have captivated the attention of the medical community. Objectives: The aim of our study was to evaluate whether these markers are effective in distinguishing varying degrees of obesity and MetS in children and adolescents. Methods: We conducted a retrospective study. A total of 71 children and adolescents, aged between 6 and 16, were included in the study. Among them, 5 were overweight, 35 had obesity, and 31 had severe obesity. According to the NCEP ATP III criteria, 32 individuals had Metabolic Syndrome (MetS), while 39 did not have MetS. Results: The MetS positive group had higher values of TG/HDL-C (p < 0.001), TC/HDL-C (p < 0.001), MHR (p = 0.015), LHR (p = 0.001), NHR (p = 0.001), atherogenic index of plasma (p < 0.001), and PHR (p < 0.001). ESR, NLR, PLR, and SII did not progressively increase with the number of MetS criteria. The ROC curve analysis demonstrated that markers such as TG/HDL-C, the atherogenic index of plasma, TC/HDL-C, LHR, NHR, and PHR were effective in identifying MetS in children and adolescents with obesity. Conclusions: In conclusion, we determined that some novel inflammatory and cardioembolic indexes are useful in assessing MetS and obesity in children and adolescents.

28 June 2023 in Biomedical Reports
Verified
Journal Article
Open access
PDF file
VPVlad Pădureanu
Vlad Pădureanu
CACarmen Valeria Albu
Carmen Valeria Albu
DCDaniel Cosmin Caragea
Daniel Cosmin Caragea
Ana Maria BugaAna Maria Buga
Ana Maria Buga
MFMirela Marinela Florescu
Mirela Marinela Florescu
ATAdina Turcu‑Știolică
Adina Turcu‑Știolică
The aim of the present study was to determine the health‑related quality of life of stroke patients and their caregivers during the fifth wave of the COVID‑19 pandemic. A total of 70 patients who had been diagnosed with stroke between October 2021 and March 2022 and 70 caregivers were included in the present study. A prospective follow‑up study assessing the quality of life at baseline was conducted after 3 months for both patients and their caregivers. A linear regression analysis was performed to evaluate potential associations between quality of life and assessed factors. The results revealed that age, sex, employment status, hospitalization period, type of stroke, Barthel index for activities of daily living (ADL) and discharge Modified Rankin Scale (mRS), were significant determinants of the 90‑day Health‑Related Quality of Life (HRQoL). An important clinical change in the QoL score was estimated for both post‑stroke patients and their caregivers. The decrease of the HRQoL of patients was statistically influenced by a higher value of ADL (P=0.014), whereas, in the case of their caregivers, the decrease of HRQoL was primarily influenced by the QoL of patients after 3 months (P=0.043). The present study identified some important key factors with direct consequences on HRQoL regarding stroke survivors and their caregivers.

Verified
Journal Article
Open access
PDF file
Mihaela Andreea PodeanuMihaela Andreea Podeanu
Mihaela Andreea Podeanu
SVStefanita Bianca vintilescu
Stefanita Bianca vintilescu
RSRaluca Elena Sandu
Raluca Elena Sandu
Claudiu Marinel IoneleClaudiu Marinel Ionele
Claudiu Marinel Ionele
CNCarmen Elena Niculescu
Carmen Elena Niculescu
MIOARA DESDEMONA STEPANMIOARA DESDEMONA STEPAN
MIOARA DESDEMONA STEPAN
This study analyzed the relationship between obesity, metabolic syndrome (MetS) and its individual components, iron metabolism, and hepatic alterations in a pediatric group of patients. We mostly concentrated on the role of serum ferritin as a marker of inflammation. We conducted a retrospective study, in which we determined the presence of MetS and hepatic ultrasound changes in a cohort of 68 pediatric patients and examined the changes in serum iron and ferritin levels. MetS prevalence was significantly higher in obese children (64%) compared to those with average weight (11.1%). Abdominal circumference, triglycerides, and high-density lipoprotein cholesterol were the most relevant MetS criteria. Serum iron levels were significantly lower, while ferritin levels increased proportionally with MetS number of components. Liver ultrasound findings confirmed a strong association between hepatic steatosis and MetS, with advanced ultrasonographic scores correlating with increased ferritin and serum iron deficiency. These results reinforce the interplay between iron metabolism and inflammation in pediatric MetS. Given this study’s unicentric design and limited ethnic diversity, further large-scale, longitudinal studies are needed to confirm these findings and improve early screening strategies for pediatric metabolic complications.